How can proton pump inhibitors damage central and peripheral nervous systems?
Tigran Makunts
Ruben Abagyan
1.Skaggs School of Pharmacy and Pharmaceutical Sciences,University of California,San Diego,La Jolla,CA,USA2.Skaggs School of Pharmacy and Pharmaceutical Sciences,University of California,San Diego,La Jolla,CA,USA
摘要：Proton-pump inhibitors (PPIs) are first line therapy for most gastroesophageal acid-related disorders.They include reflux disorders,Helicobacter pylori infections,Zollinger-Ellison syndrome,and gastroesophageal malignancies.
机标关键词：
论文发表日期：2020-11-28
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：2( 2041-2042 )